Roivant Sciences’ $400 Million At-The-Market Offering

Davis Polk advised Roivant Sciences Ltd. in the offering.Roivant Sciences Ltd. announced its at-the-market offering program under which Roivant may issue and sell its common shares through…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Laura Testa

Author: Laura Testa

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here